Gene · 3207
Papers1,952
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,952
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mitochondria dysfunction and increased expression of WNT5A and BNIP3 in tenocytes obtained from patients with tendinopathy. | JSES Int | 2026 | 41550705 | PubTator, text mining | PubMed |
| Long non-coding RNAs and therapeutic resistance in multiple myeloma: from molecular insights to clinical applications. | Clin Exp Med | 2026 | 41547689 | PubTator, text mining | PubMed |
| Molecular Landscape in Limb Anomalies: Diagnostic Yield and New Candidate Genes. | Clin Genet | 2026 | 40842263 | PubTator, text mining | PubMed |
| Integrating multi-omics and clinical features to model survival in epithelial ovarian cancer subtypes. | Sci Rep | 2025 | 41419500 | PubTator, text mining | PubMed |
| HOXA10 and HOXA11 Methylation: Epigenetic Barriers to Endometrial Receptivity in ART. | Genes (Basel) | 2025 | 41153447 | PubTator, text mining | PubMed |
| LncRNA HOXA11-AS promotes the cell proliferation, migration, invasion and inhibits cell apoptosis in esophageal squamous cell carcinoma. | Sci Rep | 2025 | 41006771 | PubTator, text mining | PubMed |
| Regulation of cisplatin resistance in lung cancer by epigenetic mechanisms. | Clin Epigenetics | 2025 | 40851017 | PubTator, text mining | PubMed |
| Author Correction: Clinical significance and effect of lncRNA HOXA11-AS in NSCLC: a study based on bioinformatics, in vitro and in vivo verification. | Sci Rep | 2025 | 40764344 | PubTator, text mining | PubMed |
| "Molecular pigeon" network of lncRNA and miRNA: decoding metabolic reprogramming in patients with lung cancer. | Front Oncol | 2025 | 40746614 | PubTator, text mining | PubMed |
| Epigenetic regulation of cancer stemness. | Signal Transduct Target Ther | 2025 | 40744921 | PubTator, text mining | PubMed |
Immune microenvironment heterogeneity characterizes biologically distinct KRASmut/SPOPmut and KRASmut/PIK3CAmut mesonephric-like adenocarcinoma subtypes revealed by integrated whole-exome and transcriptomic profiling. | Front Immunol | 2025 | 40740763 | PubTator, text mining | PubMed |
| Effects of standard and low doses of estradiol on markers of endometrial receptivity in frozen-thawed embryo transfer cycles: Double-blind, randomized clinical trial. | PLoS One | 2025 | 40720435 | PubTator, text mining | PubMed |
| Multifaceted regulation of the HOX cluster and its implications in oral cancer. | Clin Epigenetics | 2025 | 40676709 | PubTator, text mining | PubMed |
| The Rise of Mechanobiology for Advanced Cell Engineering and Manufacturing. | Adv Mater | 2025 | 40576525 | PubTator, text mining | PubMed |
| Thin endometrium restricts peri-ovulatory physiological transition between anti-adhesive and adhesive receptivity modulators. | Reprod Biomed Online | 2025 | 40543138 | PubTator, text mining | PubMed |
| EZH2: A Crucial Competing Endogenous RNA in Cancer Research-A Scoping Review. | Adv Biomed Res | 2025 | 40519579 | PubTator, text mining | PubMed |
| Transcriptional landscape of pleural mesothelioma patients in relation to NF2 gene mutational status. | J Egypt Natl Canc Inst | 2025 | 40484892 | PubTator, text mining | PubMed |
| The role of long non-coding ribonucleic acid HOXA11-AS in endometriosis therapy. | Reprod Biol Endocrinol | 2025 | 40457415 | PubTator, text mining | PubMed |
| Long non-coding RNA HOXA11-AS inhibits apoptosis, induces proliferation, and promotes autophagy via the miR-214-3p/ATG12 axis in acute T lymphoblastic leukemia. | J Mol Histol | 2025 | 40418508 | PubTator, text mining | PubMed |
| Impact of hysterosalpingography on endometrial HOXA-10 and HOXA-11 mRNA expression: A clinical trial. | Medicine (Baltimore) | 2025 | 40355241 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3207/papers?page=2